Genetic associations of the response to inhaled corticosteroids in children during an asthma exacerbation

Pediatric Allergy and Immunology

Volumn 27, Issue 5, 2016, Pages 507-513

  Keskin, Ozlem ^a   Uluca, Ünal ^a   Birben, Esra ^b   Coşkun, Yavuz ^a   Ozkars, Mehmet Yasar ^a   Keskin, Mehmet ^a   Kucukosmanoglu, Ercan ^a   Kalayci, Omer ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

asthma; child; exacerbation; gene; inhaled corticosteroid; pharmacogenetics

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; FLUTICASONE PROPIONATE; GLUCOCORTICOID INDUCED TRANSCRIPT 1; GLUCOCORTICOID RECEPTOR; MONTELUKAST; OXYGEN; SALBUTAMOL; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BOY; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG MEGADOSE; DYSPNEA; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GIRL; HUMAN; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; NEBULIZATION; NEBULIZER; OUTCOME ASSESSMENT; OXYGEN SATURATION; PEAK EXPIRATORY FLOW; PHARMACOGENETICS; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; SPIROMETRY; TREATMENT RESPONSE; VOMITING;

EID: 84978253808     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12566     Document Type: Article

References (39)

1. National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007: 120(Suppl. 5): S94–138.
2. Szefler SJ, Martin RJ, King TS, et al. Asthma clinical research network of the national heart lung, and blood institute. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002: 109: 410–8.
3. Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005: 115: 233–42.
4. Inglis GC, Ingram MC, Holloway CD, et al. Familial pattern of corticosteroids and their metabolism in adult human subjects–the Scottish Adult Twin Study. J Clin Endocrinol Metab 1999: 84: 4132–7.
5. From the Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). 2015. Available from: http://www.ginasthma.org/.
6. Fitzpatrick AM, Teague WG, Meyers DA, et al. National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 2011: 127: 382–389.
7. Howrylak JA, Fuhlbrigge AL, Strunk RC, Zeiger RS, Weiss ST, Raby BA; Childhood Asthma Management Program Research Group. Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications. J Allergy Clin Immunol 2014: 133: 1289–300, 1300.e1-12.
8. Dougherty RH, Fahy JV. Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy 2009: 39: 193–202.
9. Mori H, Tanaka H, Ohno Y, et al. Effect of intermittent systemic corticosteroid on bone metabolism in bronchial asthma patients. J Asthma 2009: 46: 142–6.
10. Satyanarayanasetty D, Pawar K, Nadig P, Haran A. Multiple adverse effects of systemic corticosteroids: a case report. J Clin Diagn Res 2015: 9: FD01–2.
11. Rodrigo GJ. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. Am J Respir Crit Care Med 2005: 171: 1231–6.
12. Lee-Wong M, Dayrit FM, Kohli AR, Acquah S, Mayo PH. Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma. Chest 2002: 122: 1208–13.
13. Edmonds ML, Milan SJ, Camargo CA Jr, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2012: 12: CD002308.
14. Tantisira KG, Lake S, Silverman ES, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004: 13: 1353–9.
15. Tantisira KG, Hwang ES, Raby BA, et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl AcadSci U S A 2004: 101: 18099–104.
16. Tantisira KG, Silverman ES, Mariani TJ, et al. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy ClinImmunol 2007: 120: 1285–91.
17. Qureshi F, Pestian J, Davis P, Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998: 339: 1030–5.
18. Guidelines for the Diagnosis and Management of Asthma. 1991. Bethesda, Md: National Heart, Lung, and Blood Institute. [NIH publication no. 91-3042.].
19. Global Initiative for Asthma. NHLBI/WHO Workshop Report:Global Strategy for Asthma Management and Prevention (revised 2009). Available at: http://www.ginasthma.com [accessed 18.08.10].
20. Belda J, Margarit G, Martínez C, et al. Anti-inflammatoryeffects of high-doseinhaledfluticasoneversus oral prednisone in asthmaexacerbations. Eur Respir J 2007: 30: 1143–1149.
21. Tantisira KG, Lasky-Su J, Harada M, et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med 2011: 365: 1173–83.
22. Tantisira KG, Damask A, Szefler SJ, et al.; SHARP Investigators. Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus. Am J RespirCrit Care Med 2012: 185: 1286–91.
23. Derijk RH, de Kloet ER. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur J Pharmacol 2008: 583: 303–11.
24. Panek M, Pietras T, Fabijan A, et al. Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypes. Exp Ther Med 2013: 5: 572–580.
25. Pietras T, Panek M, Tworek D, et al. The Bcl I single nucleotide polymorphism of the human glucocorticoid receptor gene h-GR/NR3C1 promoter in patients with bronchial asthma: pilot study. Mol Biol Rep 2011: 38: 3953–8.
26. van Rossum EF, Koper JW, van den Beld AW, et al. Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin Endocrinol (Oxf) 2003: 59: 585–92.
27. De Iudicibus S, Franca R, Martelossi S, Ventura A, Decorti G. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol 2011: 17: 1095–108.
28. Cuzzoni E, De Iudicibus S, Bartoli F, Ventura A, Decorti G. Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. Br J Clin Pharmacol 2012: 73: 651–5.
29. Just J, Gouvis-Echraghi R, Rouve S, Wanin S, Moreau D, Annesi-Maesano I. Two novel, severe asthma phenotypes identified during childhood using a clustering approach. Eur Respir J 2012: 40: 55–60.
30. Edmonds ML, Camargo CA Jr, Pollack CV Jr, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2003: 3: CD002308.
31. Schäcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002: 96: 23–43.
32. Fuhlbrigge A, Peden D, Apter AJ, et al. Asthma outcomes: exacerbations. J Allergy ClinImmunol. 2012: 129(Suppl. 3): S34–48.
33. Langhan ML, Spiro DM. Portable spirometry during acute exacerbations of asthma in children. J Asthma 2009: 46: 122–5.
34. Schneider WV, Bulloch B, Wilkinson M, Garcia-Filion P, Keahey L, Hostetler M. Utility of portable spirometry in a pediatric emergency department in children with acute exacerbation of asthma. J Asthma 2011: 48: 248–52.
35. Tan CC, McDowell KM, Fenchel M, Szczesniak R, Kercsmar CM. Spirometry use in children hospitalized with asthma. Pediatr Pulmonol 2014: 49: 451–7.
36. Silverman RA, Flaster E, Enright PL, Simonson SG. FEV1 performance among patients with acute asthma: results from a multicenter clinical trial. Chest 2007: 131: 164–71.
37. Baptist AP, Shah B, Wang Y, Ager J, Badr MS. Exhaled nitric oxide levels during treatment in patients hospitalized with asthma. Allergy Asthma Proc 2008: 29: 171–6.
38. Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev 2011: 242: 10–30.
39. Inman MD, O'Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med 1996: 153: 65–9.